TOM ROCKET LIMITED

Financial Health Score: B- (Stable but Vulnerable)

Explanation: Tom Rocket Limited is like a patient who has recovered from a severe, life-threatening illness (negative equity in 2017 and 2020) but is currently experiencing a mild relapse in symptoms. While the company's overall vital signs have stabilized with positive net assets, the recent return to a trading loss and severely depleted cash reserves indicate a fragile constitution. The business is surviving, but not thriving, and remains heavily reliant on the collection of outstanding debts to maintain healthy circulation.

Key Vital Signs

1. Solvency (Heartbeat): Recovering but Weakening * Metric: Net Assets / Shareholders' Funds * Reading: £50,552 (2024), down slightly from £52,281 (2023). * Interpretation: The patient’s heart is beating steadily. The recovery from a deep state of financial shock (-£87,885 net assets in 2020) to positive equity by 2022 was remarkable. However, the slight decline in retained earnings (from £52,181 to £50,452) shows a small loss of £1,729 in 2024, indicating the heartbeat is currently losing a bit of rhythm.

2. Liquidity (Blood Pressure): Strong on Paper, but Circulation is Slow * Metric: Current Assets vs. Current Liabilities * Reading: £87,423 in Current Assets vs. £38,931 in Current Liabilities (Current Ratio of 2.24:1). * Interpretation: The blood pressure reading looks healthy. The company has more than enough assets to cover its immediate debts. However, £84,198 of these current assets are locked up in debtors (money owed to the company). Until these invoices are collected, the cash cannot circulate properly.

3. Cash Reserves (Hydration): Dangerously Low * Metric: Cash at Bank * Reading: £3,225 (2024), only marginally up from £3,018 (2023). * Interpretation: The patient is severely dehydrated. With only £3,225 in the bank to cover £38,931 in immediate liabilities, the business cannot survive long without collecting the money owed by its debtors. This low level of liquid hydration leaves the company highly vulnerable to unexpected shocks.

4. Debt Levels (Cholesterol): Significantly Cleared * Metric: Total Liabilities * Reading: £38,931 (2024), down drastically from £189,312 (2023). * Interpretation: The patient has successfully cleared blocked arteries. The massive reduction in liabilities—specifically "Other Creditors" which dropped from £159,272 to just £7,909—suggests a major debt or related-party loan was paid off or restructured. This is a very positive step for long-term health.

Diagnosis

Condition: Chronic Cash Flow Malaise following Major Debt Clearance

The financial data reveals a business that has undergone significant surgery to remove a major liability from its balance sheet. The simultaneous drop in debtors (trade debtors fell from £150,183 to £0, though "other debtors" remain at £83,751) and creditors strongly suggests a settlement of a large, related-party or intercompany balance in 2023.

While the balance sheet looks much leaner and healthier from a liability perspective, the underlying business operations are showing symptoms of distress. The 2024 fiscal year resulted in a small loss (£1,729), and cash generation is practically stagnant. The company is entirely dependent on the collectability of its "other debtors" (£83,751) to remain solvent in the short term. If these debtors default, the company’s healthy blood pressure will plummet rapidly into a state of insolvency. Additionally, the recent resignation of the director (M. Loizakos, recorded as May 2026, which may indicate a forthcoming or recently filed change) introduces a potential risk to corporate governance, leaving the company under the full control of the 75%+ shareholder, Wolfgang Weidmann.

Recommendations

1. Intravenous Cash Flow Support (Debt Collection): The most urgent treatment is to aggressively collect the £83,751 owed in "other debtors." The business cannot function on £3,225 of cash. Implement strict credit control procedures to convert these receivables into cash immediately.
2. Nutritional Boost (Revenue Generation): The slight loss in 2024 indicates the business is not generating enough nourishment to sustain itself. Review the core "Other publishing activities" to identify new revenue streams or adjust pricing to return to profitability.
3. Monitor the "Other Debtors" (Biopsy): Given that trade debtors dropped to zero, the £83,751 in "other debtors" is highly suspect and may represent loans to directors or related parties. Investigate the nature of this balance; if it is not recoverable, it should be written off to prevent a toxic build-up in the system.
4. Governance Checkup: With the sole listed director having resigned, ensure that new, competent leadership is appointed to steer the company and maintain statutory compliance, preventing administrative decay.